Literature DB >> 511355

Trimethoprim/sulphonamide: concluding remarks.

W Marget.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 511355     DOI： 10.1007/bf01639026

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  20 in total

1.  Comparison of long- and short-term treatment of recurrent urinary tract infection.

Authors:  W Marget; B H Belohradsky; B Nickel
Journal:  Infection       Date:  1979       Impact factor: 3.553

2.  Double-blind comparison of sulphonamide-trimethoprim combinations in acute uncomplicated urinary tract infections.

Authors:  O Skjerven; T Bergan
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  Synergistic activity of co-trimazine and co-trimoxazole in the urine.

Authors:  J Acar; B Ekström; H Fellner; U Forsgren; J Guibert; B Huitfeldt; M D Kitzis; L Magni; B Ortengren
Journal:  Infection       Date:  1979       Impact factor: 3.553

4.  Clinical studies on co-trimazine in children.

Authors:  P G Bergfors
Journal:  Infection       Date:  1979       Impact factor: 3.553

5.  Efficacy of two trimethoprim-sulphonamide combinations in experimental pyelonephritis in the rat.

Authors:  W Ritzerfeld
Journal:  Infection       Date:  1979       Impact factor: 3.553

6.  Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part I: Comparison of the antibacterial effect of sulphonamides alone and in combination with trimethoprim.

Authors:  B Ekström; U Forsgren; B Ortengren; T Bergan
Journal:  Infection       Date:  1979       Impact factor: 3.553

7.  The effect of trimethoprim-sulphonamide, trimethoprim and sulphonamide on the occurrence of resistant enterobacteriaceae in human intestinal flora.

Authors:  H Knothe
Journal:  Infection       Date:  1979       Impact factor: 3.553

8.  A clinical study of co-trimazine in comparison with co-trimoxazole and sulphalene in urinary tract infections.

Authors:  A Lövestad; B Gästrin; R Lundström
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 9.  The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues.

Authors:  D S Reeves; P J Wilkinson
Journal:  Infection       Date:  1979       Impact factor: 3.553

10.  Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim.

Authors:  B Ortengren; L Magni; T Bergan
Journal:  Infection       Date:  1979       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.